Cognex Corporation (CGNX) Stock Price, News, Analysis | DailyIQ

|

Technical Score (1D)

68

BULLISH

News Sentiment

64

BULLISH

On Oct 6, a comparative analysis reported that Cognex Corporation (CGNX) had posted stronger year‑to‑date returns than many of its Computer and Technology peers. The study noted that CGNX sits in the top tier of its sector, holding a Zacks Rank of #1 (Strong Buy). Analysts highlighted that the company’s earnings outlook is improving, which could position it to outperform the market over the next one to three months. The data also placed CGNX in the overall #4 Zacks Sector Rank for the Computer and Technology group. These findings suggest that investors may view CGNX as a compelling pick within the broader tech landscape.

CGNX|Analyst Targets

LOW TARGET

$65 -2.0%

2 analysts

MEAN TARGET

$80 +19.9%

16 analysts

HIGH TARGET

$92 +38.7%

12 analysts

PRICE RANGE

$65.00 - $92.00

SB / B / H / S / SS

5/15/8/1/1

DAILYIQ EST.

$81.78 (+23.3%)

CGNX|Insider Trading

Bought (1Y)

0 shares

$0

Sold (1Y)

44,166 shares

$2.9M

Moschner MatthewCEO & President

Option Exercise1,600 shares2026-08-11

Moschner MatthewCEO & President

Option Exercise7,000 shares2026-08-11

Moschner MatthewCEO & President

Option Exercise4,000 shares2026-08-11

Moschner MatthewCEO & President

Sell8,362 shares2026-08-11

Moschner MatthewCEO & President

Sell7,000 shares2026-08-11

CGNX|Fundamentals

Bullish

Overall: Bullish

✓Revenue growing year over year

✓Positive net margin

✓Positive operating cash flow

Gross Margin

66.9%

Net Margin

11.5%

Revenue CAGR

8.7%

Current Ratio

3.80x

Return on Equity

7.7%

CGNX|Earnings Snapshot

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q3'26	$0.52	-	-
Q3'25	$0.29	$0.33	+13.5%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q3'26	$320M	-	-
Q3'25	-	$277M	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

CGNX|Monthly Returns

Market Data

CGNX Stock Snapshot

BULLISH68/100

$66.29−$0.08 (0.1%)

Market cap: 10.85B
P/E ratio: 62.1
Day range: $64.40 – $66.61
News sentiment: 64/100 · Bullish
Analyst target: $79.58 (+20.0%)
Consensus: Buy · 30 analysts

52-week range+91.6% off low · -11.6% from high

$34.60$74.97

Price $66.29 DailyIQ Est. $81.78

Price is in the upper part of its 52-week range, and the momentum read backs that positioning up. Institutional coverage is thorough here, so shifts in analyst expectations show up in price quickly.

Behaviour On Record

What CGNX's own history says about today's numbers

Realized volatility (21d): 52.1% 82nd pct
Below its peak: -33.4%
vs 200-day average: +15.0%
Up days (1y): 50%

Cognex Corporation is currently running 52.1% annualised volatility over the last 21 sessions. Measured against CGNX's own 13 years of daily returns rather than a market-wide average, that is the 82nd percentile — elevated for this stock, against a typical reading of 33.7%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

CGNX is trading -33.4% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -34.1%, and the deepest was -49.8% in 2018. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +15.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 69th percentile — a somewhat wider gap than its own norm. Over the past year CGNX closed higher on 50% of sessions, and it is currently 1 session into a falling streak.

On October specifically: over 13 years of records, CGNX finished the month higher 9 of 13 times, with a median return of +2.8% and an average of +0.2%. Its strongest month historically has been July at +7.4% on average, its weakest April at -1.3%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: CGNX has opened more than 2% away from the prior close in 254 of 3,267 sessions (7.8% of the time), with the largest gaps running +6.4% and -12.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

All figures computed from 3,268 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against CGNX's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of CGNX's sector?

Cognex Corporation sits in the Industrials sector, currently ranked 5th of 12 GICS sectors by relative-strength rotation score (improving).

Sector rank: #5 of 12
Sector state: Improving
Sector rotation score: 55

Options Market

What is the options market pricing for CGNX?

CallsPuts

For Cognex Corporation's nearest expiry (2026-10-16, 10 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 1.46), with at-the-money implied volatility around 75.5%. The options market is pricing roughly a ±10.4% move by that expiry — a range of about $53.03–$65.39.

Put/call ratio (2026-10-16): 1.46
ATM implied volatility: 75.5%
Total open interest: 3,013
Expected move by 2026-10-16: ±10.4% ($53.03–$65.39)

Analyst Rating Changes

Are analysts turning bullish or bearish on CGNX?

DA Davidson most recently reiterated its rating on Cognex Corporation to Neutral on Sep 23, 2026 with a price target of $65. Over the last 90 days, coverage has run 0 upgrades against 1 downgrade, a net bearish lean.

Latest action: DA Davidson — Neutral
90-day upgrades: 0
90-day downgrades: 1
Net rating momentum: -1

Date	Firm	Action	Rating	Price target
Sep 23, 2026	DA Davidson	Maintained	Neutral	$65
Sep 23, 2026	Baird	Maintained	Neutral	$78 → $70
Sep 15, 2026	Needham	Reiterated	Buy	$80
Aug 10, 2026	DA Davidson	Maintained	Neutral	$62 → $65
Aug 10, 2026	HSBC	Downgrade	Buy → Hold	-
Aug 10, 2026	Barclays	Maintained	Overweight	$75 → $80
Aug 7, 2026	Citigroup	Maintained	Neutral	$72 → $74
Aug 7, 2026	Needham	Maintained	Buy	$75 → $80
Aug 7, 2026	Truist Securities	Maintained	Hold	$71 → $78
Aug 7, 2026	Cantor Fitzgerald	Maintained	Overweight	$76 → $84
Jul 13, 2026	Citigroup	Maintained	Neutral	$68 → $72
Jul 2, 2026	Truist Securities	Maintained	Hold	$61 → $71

Held by These ETFs

CGNX is a top holding in these ETFs tracked on DailyIQ — bar length shows portfolio weight.

News Sentiment Analysis

Sentiment gathered from recent headlines

64/100

Strong NegativeNeutralStrong Positive

MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Cognex Corporation received a Zacks Rank of #1 (Strong Buy) as its full‑year earnings estimate rose 13.5% over the past 90 days. The company’s performance outpaces many peers in the Computer and Technology sector, placing it near the top of the Zacks Sector Rank. Analysts view the upward revision as a sign of improving earnings outlook, suggesting potential upside for investors.

What did this article say?

Truist Securities analyst Jamie Cook kept Cognex (CGNX) on a Hold rating while reducing the target price from $78 to $74. The downgrade reflects concerns about the company’s valuation relative to peers and potential earnings pressure. The move signals a modest negative outlook for the stock, though the firm remains neutral on the company’s fundamentals. Investors may view the adjustment as a warning of limited upside potential in the near term.

What did this article say?

Truist Securities reduced its price target for Cognex (CGNX) from $78 to $74 while keeping a hold recommendation. The downgrade reflects a reassessment of the company’s valuation relative to peers. The move signals a modest negative outlook for CGNX’s near‑term performance. No immediate catalysts were cited, and the rating change is considered a routine adjustment.

What did this article say?

In September 2026 Cognex Corporation introduced the In‑Sight 1750 Series, an AI‑powered wafer and panel identification system designed to enhance traceability and reduce production disruptions for semiconductor manufacturers. The new system can read degraded marks on challenging substrates and supports seamless upgrades from the earlier In‑Sight 1740 model, allowing factories to maintain throughput without major process changes. By addressing a critical factory‑floor problem, the launch strengthens Cognex’s position in the AI‑enabled machine vision market and provides a near‑term catalyst for revenue growth in the semiconductor segment.

What did this article say?

Cognex Corporation (CGNX) received a Hold rating from an analyst, citing its differentiated AI‑enhanced offerings as a strength. The analyst highlighted benefits from infrastructure spending on AI data centers, vision in robotics, and new form factors. However, concerns over Chinese competition tempered the outlook, leading to a cautious stance. The recommendation reflects a balance between growth potential and competitive risks.

What did this article say?

Cognex (CGNX) benefited from rising demand in logistics, packaging, consumer electronics and semiconductors, driving recent share gains. The company’s AI‑enabled products, including OneVision and the RealSense acquisition, broaden its addressable market but are unlikely to generate a sharp near‑term growth surge. Guidance indicates that growth will moderate in the second half of the year, with short‑term multiple expansion deemed unlikely. Nonetheless, the RealSense acquisition positions CGNX to capture upside if humanoid robotics gain traction. Overall, the outlook is positive but tempered by modest near‑term upside expectations.

What did this article say?

Cognex announced the acquisition of 3D vision specialist RealSense for approximately US$500 million, expanding its product portfolio into semiconductor inspection. The company also unveiled the In‑Sight 1750 wafer identification system, targeting high‑volume semiconductor customers. The combined transaction and product launch reinforce CGNX’s position in the vision‑based inspection market and signal continued growth momentum. The deal aligns with the company’s strategy to broaden its industrial automation solutions and enhance revenue streams. Investors viewed the announcement as a positive catalyst for future earnings.

What did this article say?

Cognex’s stock has risen sharply year‑to‑date, prompting concerns about whether the current price aligns with earnings. The planned US$500 million acquisition of RealSense, financed from cash and investments, could alter the company’s earnings trajectory by accelerating its robotic vision integration. Analysts debate whether the share price reflects realistic future cash flows. The valuation debate highlights potential upside risk if the deal’s benefits are overstated.

What did this article say?

Cognex (CGNX) unveiled its In‑Sight 1750 Series wafer and panel identification system, aimed at enhancing traceability for semiconductor manufacturers. The platform blends AI, advanced imaging and custom illumination to read degraded wafer markings and challenging substrates. It is designed to integrate with existing production lines and support future upgrades, simplifying deployment and process control. The announcement signals a new product line that could strengthen CGNX’s position in the semiconductor inspection market, though shares dipped slightly in early trading.

What did this article say?

Cognex Corporation (CGNX) has launched the In‑Sight 1750 Series, a next‑generation wafer and panel identification system aimed at reducing production disruptions and improving traceability for semiconductor manufacturers. The system leverages advanced AI, imaging, and illumination to reliably read degraded wafer markings and challenging substrates, thereby maintaining throughput as demand for AI and advanced computing chips rises. By addressing a critical bottleneck in wafer tracking, the product positions CGNX to capture growing market share in the semiconductor equipment sector.

Technical Analysis

Real-time indicators across multiple timeframes

68

BULLISH

Technical indicators reflect the latest computed signal mix for this timeframe.

Unlock full technicals

Create a free account to access more indicators and deeper timeframe data.

Institutional & Hedge Fund Ownership

2 tracked managers · $37.38M combined position · 0 adding, 1 trimming, 1 unchanged (latest 13F filings)

Manager	Trend	Shares Held	% of Co.	Position Value	Filed
Engaged Capital LLC	▼ Sell	339,000	0.21%	$24.55M	2026-08-14
Citadel Advisors LLC	• Hold	177,200	0.11%	$12.83M	2026-09-02

Q2 2026 flow:177.2K sh bought ($12.83M)145.0K sh sold ($10.50M)net +32.2K sh (+$2.33M)

Congressional Trading Activity

3 disclosed trades · ~$73.0K est. traded value · 1 buys, 2 sells

Member	Chamber	State	Type	Amount	Traded	Filed
Sheldon Whitehouse	Senate	RI	▼ Sell	$15K - $50K	2020-03-11	2020-04-14
Sheldon Whitehouse	Senate	RI	▲ Buy	$15K - $50K	2019-04-18	2019-05-08
Thom Tillis	Senate	NC	▼ Sell	$1K - $15K	2015-02-13	2015-02-26